Industry Research Reports

Home > Reports > Chemical & Material > Nicotinamide Riboside (NR)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Nicotinamide Riboside (NR)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Chemical & Material

Published Date: 2025-01-19

Pages: 112 Pages

Report ld: 3529414

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Nicotinamide Riboside (NR) Market Size(US$)

CAGR 2025-2031

8.3%

Market Size,2031

USD 44.8

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 27.7 million

Market Forecast in 2031(Value)

US$ 44.8 million

CAGR

8.3%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Nicotinamide Riboside (NR) was estimated to be worth US$ 25.8 million in 2024 and is forecast to a readjusted size of US$ 44.8 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.

Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.

In fact, the market’s mainstream is selling NRC powder, the full name called nicotinamide riboside chloride. NRC is a chloride form of NR. 100 mg of nicotinamide riboside chloride provides about 88 mg of nicotinamide riboside. The report focuses on the Nicotinamide Riboside(NR) market, which has been converted.

The global Nicotinamide Riboside (NR) market was valued at US$ 21.46 million in 2022 and will reach US$ 38.76 million by the end of 2029, growing at a CAGR of 8.32% during 2023-2029.

The data for 2023 is an estimate, based on the historical data and the integrated view of industrial experts, manufacturers, distributors, and end users, etc.

Top-down and bottom-up approaches are used to validate the global Nicotinamide Riboside (NR) market size and to estimate the market size for company, regional division, product type and application (end users). In the complete market engineering process, both top-down and bottom-up approaches along with several data triangulation methods have been extensively utilized to perform market estimation and market forecast for the overall market division and subdivision listed in this report. Extensive qualitative and further quantitative analysis has also been done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Global key players of Nicotinamide Riboside (NR) include ChromaDex, Genex Formulas, Shandong Tianming Pharmaceutical, Bontac, Longer Livetech, etc. The top three players hold a share over 60%.

Asia-Pacific is the largest market, has a share about 39%, followed by North America, and Europe, with share 35% and 16%, separately.

In terms of product type, purity below 98% is the largest segment, occupied for a share of 63%, and in terms of application, health supplement has a share about 92 percent.

This report aims to provide a comprehensive presentation of the global market for Nicotinamide Riboside (NR), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Nicotinamide Riboside (NR) by region & country, by Type, and by Application.

The Nicotinamide Riboside (NR) market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicotinamide Riboside (NR).

MARKET SEGMENTATION

By Company

ChromaDex
Genex Formulas
Shandong Tianming Pharmaceutical
Bontac
Longer Livetech
Tiantai Biotechnology
EnzymeWorks
Suzhou MyLand Pharm & Nutrition
Shenzhen Ejion Biotechnology
Zhejiang Jiahua
Weitai Pharmaceutical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Purity ≤98%
Purity ＞98%

Segment by Application

Health Supplement
Pharmaceutical Additives

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Nicotinamide Riboside (NR) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Nicotinamide Riboside (NR) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Nicotinamide Riboside (NR) in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Nicotinamide Riboside (NR) Product Introduction

1.2 Global Nicotinamide Riboside (NR) Market Size Forecast

1.2.1 Global Nicotinamide Riboside (NR) Sales Value (2020-2031)

1.2.2 Global Nicotinamide Riboside (NR) Sales Volume (2020-2031)

1.2.3 Global Nicotinamide Riboside (NR) Sales Price (2020-2031)

1.3 Nicotinamide Riboside (NR) Market Trends & Drivers

1.3.1 Nicotinamide Riboside (NR) Industry Trends

1.3.2 Nicotinamide Riboside (NR) Market Drivers & Opportunity

1.3.3 Nicotinamide Riboside (NR) Market Challenges

1.3.4 Nicotinamide Riboside (NR) Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Nicotinamide Riboside (NR) Players Revenue Ranking (2024)

2.2 Global Nicotinamide Riboside (NR) Revenue by Company (2020-2025)

2.3 Global Nicotinamide Riboside (NR) Players Sales Volume Ranking (2024)

2.4 Global Nicotinamide Riboside (NR) Sales Volume by Company Players (2020-2025)

2.5 Global Nicotinamide Riboside (NR) Average Price by Company (2020-2025)

2.6 Key Manufacturers Nicotinamide Riboside (NR) Manufacturing Base and Headquarters

2.7 Key Manufacturers Nicotinamide Riboside (NR) Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Nicotinamide Riboside (NR)

2.9 Nicotinamide Riboside (NR) Market Competitive Analysis

2.9.1 Nicotinamide Riboside (NR) Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Nicotinamide Riboside (NR) Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Riboside (NR) as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Purity ≤98%

3.1.2 Purity ＞98%

3.2 Global Nicotinamide Riboside (NR) Sales Value by Type

3.2.1 Global Nicotinamide Riboside (NR) Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Nicotinamide Riboside (NR) Sales Value, by Type (2020-2031)

3.2.3 Global Nicotinamide Riboside (NR) Sales Value, by Type (%) (2020-2031)

3.3 Global Nicotinamide Riboside (NR) Sales Volume by Type

3.3.1 Global Nicotinamide Riboside (NR) Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Nicotinamide Riboside (NR) Sales Volume, by Type (2020-2031)

3.3.3 Global Nicotinamide Riboside (NR) Sales Volume, by Type (%) (2020-2031)

3.4 Global Nicotinamide Riboside (NR) Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Health Supplement

4.1.2 Pharmaceutical Additives

4.2 Global Nicotinamide Riboside (NR) Sales Value by Application

4.2.1 Global Nicotinamide Riboside (NR) Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Nicotinamide Riboside (NR) Sales Value, by Application (2020-2031)

4.2.3 Global Nicotinamide Riboside (NR) Sales Value, by Application (%) (2020-2031)

4.3 Global Nicotinamide Riboside (NR) Sales Volume by Application

4.3.1 Global Nicotinamide Riboside (NR) Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Nicotinamide Riboside (NR) Sales Volume, by Application (2020-2031)

4.3.3 Global Nicotinamide Riboside (NR) Sales Volume, by Application (%) (2020-2031)

4.4 Global Nicotinamide Riboside (NR) Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Nicotinamide Riboside (NR) Sales Value by Region

5.1.1 Global Nicotinamide Riboside (NR) Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Nicotinamide Riboside (NR) Sales Value by Region (2020-2025)

5.1.3 Global Nicotinamide Riboside (NR) Sales Value by Region (2026-2031)

5.1.4 Global Nicotinamide Riboside (NR) Sales Value by Region (%), (2020-2031)

5.2 Global Nicotinamide Riboside (NR) Sales Volume by Region

5.2.1 Global Nicotinamide Riboside (NR) Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Nicotinamide Riboside (NR) Sales Volume by Region (2020-2025)

5.2.3 Global Nicotinamide Riboside (NR) Sales Volume by Region (2026-2031)

5.2.4 Global Nicotinamide Riboside (NR) Sales Volume by Region (%), (2020-2031)

5.3 Global Nicotinamide Riboside (NR) Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Nicotinamide Riboside (NR) Sales Value, 2020-2031

5.4.2 North America Nicotinamide Riboside (NR) Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Nicotinamide Riboside (NR) Sales Value, 2020-2031

5.5.2 Europe Nicotinamide Riboside (NR) Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Nicotinamide Riboside (NR) Sales Value, 2020-2031

5.6.2 Asia Pacific Nicotinamide Riboside (NR) Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Nicotinamide Riboside (NR) Sales Value, 2020-2031

5.7.2 South America Nicotinamide Riboside (NR) Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Nicotinamide Riboside (NR) Sales Value, 2020-2031

5.8.2 Middle East & Africa Nicotinamide Riboside (NR) Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Nicotinamide Riboside (NR) Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Nicotinamide Riboside (NR) Sales Value

6.2.1 Key Countries/Regions Nicotinamide Riboside (NR) Sales Value, 2020-2031

6.2.2 Key Countries/Regions Nicotinamide Riboside (NR) Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Nicotinamide Riboside (NR) Sales Value, 2020-2031

6.3.2 United States Nicotinamide Riboside (NR) Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Nicotinamide Riboside (NR) Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Nicotinamide Riboside (NR) Sales Value, 2020-2031

6.4.2 Europe Nicotinamide Riboside (NR) Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Nicotinamide Riboside (NR) Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Nicotinamide Riboside (NR) Sales Value, 2020-2031

6.5.2 China Nicotinamide Riboside (NR) Sales Value by Type (%), 2024 VS 2031

6.5.3 China Nicotinamide Riboside (NR) Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Nicotinamide Riboside (NR) Sales Value, 2020-2031

6.6.2 Japan Nicotinamide Riboside (NR) Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Nicotinamide Riboside (NR) Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Nicotinamide Riboside (NR) Sales Value, 2020-2031

6.7.2 South Korea Nicotinamide Riboside (NR) Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Nicotinamide Riboside (NR) Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Nicotinamide Riboside (NR) Sales Value, 2020-2031

6.8.2 Southeast Asia Nicotinamide Riboside (NR) Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Nicotinamide Riboside (NR) Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Nicotinamide Riboside (NR) Sales Value, 2020-2031

6.9.2 India Nicotinamide Riboside (NR) Sales Value by Type (%), 2024 VS 2031

6.9.3 India Nicotinamide Riboside (NR) Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 ChromaDex

7.1.1 ChromaDex Company Information

7.1.2 ChromaDex Introduction and Business Overview

7.1.3 ChromaDex Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 ChromaDex Nicotinamide Riboside (NR) Product Offerings

7.1.5 ChromaDex Recent Development

7.2 Genex Formulas

7.2.1 Genex Formulas Company Information

7.2.2 Genex Formulas Introduction and Business Overview

7.2.3 Genex Formulas Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Genex Formulas Nicotinamide Riboside (NR) Product Offerings

7.2.5 Genex Formulas Recent Development

7.3 Shandong Tianming Pharmaceutical

7.3.1 Shandong Tianming Pharmaceutical Company Information

7.3.2 Shandong Tianming Pharmaceutical Introduction and Business Overview

7.3.3 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Product Offerings

7.3.5 Shandong Tianming Pharmaceutical Recent Development

7.4 Bontac

7.4.1 Bontac Company Information

7.4.2 Bontac Introduction and Business Overview

7.4.3 Bontac Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Bontac Nicotinamide Riboside (NR) Product Offerings

7.4.5 Bontac Recent Development

7.5 Longer Livetech

7.5.1 Longer Livetech Company Information

7.5.2 Longer Livetech Introduction and Business Overview

7.5.3 Longer Livetech Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Longer Livetech Nicotinamide Riboside (NR) Product Offerings

7.5.5 Longer Livetech Recent Development

7.6 Tiantai Biotechnology

7.6.1 Tiantai Biotechnology Company Information

7.6.2 Tiantai Biotechnology Introduction and Business Overview

7.6.3 Tiantai Biotechnology Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Tiantai Biotechnology Nicotinamide Riboside (NR) Product Offerings

7.6.5 Tiantai Biotechnology Recent Development

7.7 EnzymeWorks

7.7.1 EnzymeWorks Company Information

7.7.2 EnzymeWorks Introduction and Business Overview

7.7.3 EnzymeWorks Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 EnzymeWorks Nicotinamide Riboside (NR) Product Offerings

7.7.5 EnzymeWorks Recent Development

7.8 Suzhou MyLand Pharm & Nutrition

7.8.1 Suzhou MyLand Pharm & Nutrition Company Information

7.8.2 Suzhou MyLand Pharm & Nutrition Introduction and Business Overview

7.8.3 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Product Offerings

7.8.5 Suzhou MyLand Pharm & Nutrition Recent Development

7.9 Shenzhen Ejion Biotechnology

7.9.1 Shenzhen Ejion Biotechnology Company Information

7.9.2 Shenzhen Ejion Biotechnology Introduction and Business Overview

7.9.3 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Product Offerings

7.9.5 Shenzhen Ejion Biotechnology Recent Development

7.10 Zhejiang Jiahua

7.10.1 Zhejiang Jiahua Company Information

7.10.2 Zhejiang Jiahua Introduction and Business Overview

7.10.3 Zhejiang Jiahua Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 Zhejiang Jiahua Nicotinamide Riboside (NR) Product Offerings

7.10.5 Zhejiang Jiahua Recent Development

7.11 Weitai Pharmaceutical

7.11.1 Weitai Pharmaceutical Company Information

7.11.2 Weitai Pharmaceutical Introduction and Business Overview

7.11.3 Weitai Pharmaceutical Nicotinamide Riboside (NR) Sales, Revenue, Price and Gross Margin (2020-2025)

7.11.4 Weitai Pharmaceutical Nicotinamide Riboside (NR) Product Offerings

7.11.5 Weitai Pharmaceutical Recent Development

8 Industry Chain Analysis

8.1 Nicotinamide Riboside (NR) Industrial Chain

8.2 Nicotinamide Riboside (NR) Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Nicotinamide Riboside (NR) Sales Model

8.5.2 Sales Channel

8.5.3 Nicotinamide Riboside (NR) Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Nicotinamide Riboside (NR) Market Trends

Table 2. Nicotinamide Riboside (NR) Market Drivers & Opportunity

Table 3. Nicotinamide Riboside (NR) Market Challenges

Table 4. Nicotinamide Riboside (NR) Market Restraints

Table 5. Global Nicotinamide Riboside (NR) Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Nicotinamide Riboside (NR) Revenue Market Share by Company (2020-2025)

Table 7. Global Nicotinamide Riboside (NR) Sales Volume by Company (2020-2025) & (MT)

Table 8. Global Nicotinamide Riboside (NR) Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Nicotinamide Riboside (NR) Price by Company (2020-2025) & (US$/MT)

Table 10. Key Manufacturers Nicotinamide Riboside (NR) Manufacturing Base and Headquarters

Table 11. Key Manufacturers Nicotinamide Riboside (NR) Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Nicotinamide Riboside (NR)

Table 13. Global Nicotinamide Riboside (NR) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Riboside (NR) as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Nicotinamide Riboside (NR) Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Nicotinamide Riboside (NR) Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Nicotinamide Riboside (NR) Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Nicotinamide Riboside (NR) Sales Market Share in Value by Type (2020-2025)

Table 20. Global Nicotinamide Riboside (NR) Sales Market Share in Value by Type (2026-2031)

Table 21. Global Nicotinamide Riboside (NR) Sales Volume by Type: 2020 VS 2024 VS 2031 (MT)

Table 22. Global Nicotinamide Riboside (NR) Sales Volume by Type (2020-2025) & (MT)

Table 23. Global Nicotinamide Riboside (NR) Sales Volume by Type (2026-2031) & (MT)

Table 24. Global Nicotinamide Riboside (NR) Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Nicotinamide Riboside (NR) Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Nicotinamide Riboside (NR) Price by Type (2020-2025) & (US$/MT)

Table 27. Global Nicotinamide Riboside (NR) Price by Type (2026-2031) & (US$/MT)

Table 28. Global Nicotinamide Riboside (NR) Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Nicotinamide Riboside (NR) Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Nicotinamide Riboside (NR) Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Nicotinamide Riboside (NR) Sales Market Share in Value by Application (2020-2025)

Table 32. Global Nicotinamide Riboside (NR) Sales Market Share in Value by Application (2026-2031)

Table 33. Global Nicotinamide Riboside (NR) Sales Volume by Application: 2020 VS 2024 VS 2031 (MT)

Table 34. Global Nicotinamide Riboside (NR) Sales Volume by Application (2020-2025) & (MT)

Table 35. Global Nicotinamide Riboside (NR) Sales Volume by Application (2026-2031) & (MT)

Table 36. Global Nicotinamide Riboside (NR) Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Nicotinamide Riboside (NR) Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Nicotinamide Riboside (NR) Price by Application (2020-2025) & (US$/MT)

Table 39. Global Nicotinamide Riboside (NR) Price by Application (2026-2031) & (US$/MT)

Table 40. Global Nicotinamide Riboside (NR) Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Nicotinamide Riboside (NR) Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Nicotinamide Riboside (NR) Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Nicotinamide Riboside (NR) Sales Value by Region (2020-2025) & (%)

Table 44. Global Nicotinamide Riboside (NR) Sales Value by Region (2026-2031) & (%)

Table 45. Global Nicotinamide Riboside (NR) Sales Volume by Region (MT): 2020 VS 2024 VS 2031

Table 46. Global Nicotinamide Riboside (NR) Sales Volume by Region (2020-2025) & (MT)

Table 47. Global Nicotinamide Riboside (NR) Sales Volume by Region (2026-2031) & (MT)

Table 48. Global Nicotinamide Riboside (NR) Sales Volume by Region (2020-2025) & (%)

Table 49. Global Nicotinamide Riboside (NR) Sales Volume by Region (2026-2031) & (%)

Table 50. Global Nicotinamide Riboside (NR) Average Price by Region (2020-2025) & (US$/MT)

Table 51. Global Nicotinamide Riboside (NR) Average Price by Region (2026-2031) & (US$/MT)

Table 52. Key Countries/Regions Nicotinamide Riboside (NR) Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Nicotinamide Riboside (NR) Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Nicotinamide Riboside (NR) Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Nicotinamide Riboside (NR) Sales Volume, (2020-2025) & (MT)

Table 56. Key Countries/Regions Nicotinamide Riboside (NR) Sales Volume, (2026-2031) & (MT)

Table 57. ChromaDex Company Information

Table 58. ChromaDex Introduction and Business Overview

Table 59. ChromaDex Nicotinamide Riboside (NR) Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 60. ChromaDex Nicotinamide Riboside (NR) Product Offerings

Table 61. ChromaDex Recent Development

Table 62. Genex Formulas Company Information

Table 63. Genex Formulas Introduction and Business Overview

Table 64. Genex Formulas Nicotinamide Riboside (NR) Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 65. Genex Formulas Nicotinamide Riboside (NR) Product Offerings

Table 66. Genex Formulas Recent Development

Table 67. Shandong Tianming Pharmaceutical Company Information

Table 68. Shandong Tianming Pharmaceutical Introduction and Business Overview

Table 69. Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 70. Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Product Offerings

Table 71. Shandong Tianming Pharmaceutical Recent Development

Table 72. Bontac Company Information

Table 73. Bontac Introduction and Business Overview

Table 74. Bontac Nicotinamide Riboside (NR) Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 75. Bontac Nicotinamide Riboside (NR) Product Offerings

Table 76. Bontac Recent Development

Table 77. Longer Livetech Company Information

Table 78. Longer Livetech Introduction and Business Overview

Table 79. Longer Livetech Nicotinamide Riboside (NR) Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 80. Longer Livetech Nicotinamide Riboside (NR) Product Offerings

Table 81. Longer Livetech Recent Development

Table 82. Tiantai Biotechnology Company Information

Table 83. Tiantai Biotechnology Introduction and Business Overview

Table 84. Tiantai Biotechnology Nicotinamide Riboside (NR) Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 85. Tiantai Biotechnology Nicotinamide Riboside (NR) Product Offerings

Table 86. Tiantai Biotechnology Recent Development

Table 87. EnzymeWorks Company Information

Table 88. EnzymeWorks Introduction and Business Overview

Table 89. EnzymeWorks Nicotinamide Riboside (NR) Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 90. EnzymeWorks Nicotinamide Riboside (NR) Product Offerings

Table 91. EnzymeWorks Recent Development

Table 92. Suzhou MyLand Pharm & Nutrition Company Information

Table 93. Suzhou MyLand Pharm & Nutrition Introduction and Business Overview

Table 94. Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 95. Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Product Offerings

Table 96. Suzhou MyLand Pharm & Nutrition Recent Development

Table 97. Shenzhen Ejion Biotechnology Company Information

Table 98. Shenzhen Ejion Biotechnology Introduction and Business Overview

Table 99. Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 100. Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Product Offerings

Table 101. Shenzhen Ejion Biotechnology Recent Development

Table 102. Zhejiang Jiahua Company Information

Table 103. Zhejiang Jiahua Introduction and Business Overview

Table 104. Zhejiang Jiahua Nicotinamide Riboside (NR) Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 105. Zhejiang Jiahua Nicotinamide Riboside (NR) Product Offerings

Table 106. Zhejiang Jiahua Recent Development

Table 107. Weitai Pharmaceutical Company Information

Table 108. Weitai Pharmaceutical Introduction and Business Overview

Table 109. Weitai Pharmaceutical Nicotinamide Riboside (NR) Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2020-2025)

Table 110. Weitai Pharmaceutical Nicotinamide Riboside (NR) Product Offerings

Table 111. Weitai Pharmaceutical Recent Development

Table 112. Key Raw Materials Lists

Table 113. Raw Materials Key Suppliers Lists

Table 114. Nicotinamide Riboside (NR) Downstream Customers

Table 115. Nicotinamide Riboside (NR) Distributors List

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Nicotinamide Riboside (NR) Product Picture

Figure 2. Global Nicotinamide Riboside (NR) Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Nicotinamide Riboside (NR) Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Nicotinamide Riboside (NR) Sales Volume (2020-2031) & (MT)

Figure 5. Global Nicotinamide Riboside (NR) Sales Price (2020-2031) & (US$/MT)

Figure 6. Nicotinamide Riboside (NR) Report Years Considered

Figure 7. Global Nicotinamide Riboside (NR) Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Nicotinamide Riboside (NR) Players Sales Volume Ranking (2024) & (MT)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Nicotinamide Riboside (NR) Revenue in 2024

Figure 10. Nicotinamide Riboside (NR) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Purity ≤98% Picture

Figure 12. Purity ＞98% Picture

Figure 13. Global Nicotinamide Riboside (NR) Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Nicotinamide Riboside (NR) Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Nicotinamide Riboside (NR) Sales Volume by Type (2020 VS 2024 VS 2031) & (MT)

Figure 16. Global Nicotinamide Riboside (NR) Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Nicotinamide Riboside (NR) Price by Type (2020-2031) & (US$/MT)

Figure 18. Product Picture of Health Supplement

Figure 19. Product Picture of Pharmaceutical Additives

Figure 20. Global Nicotinamide Riboside (NR) Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 21. Global Nicotinamide Riboside (NR) Sales Value Market Share by Application, 2024 & 2031

Figure 22. Global Nicotinamide Riboside (NR) Sales Volume by Application (2020 VS 2024 VS 2031) & (MT)

Figure 23. Global Nicotinamide Riboside (NR) Sales Volume Market Share by Application, 2024 & 2031

Figure 24. Global Nicotinamide Riboside (NR) Price by Application (2020-2031) & (US$/MT)

Figure 25. North America Nicotinamide Riboside (NR) Sales Value (2020-2031) & (US$ Million)

Figure 26. North America Nicotinamide Riboside (NR) Sales Value by Country (%), 2024 VS 2031

Figure 27. Europe Nicotinamide Riboside (NR) Sales Value, (2020-2031) & (US$ Million)

Figure 28. Europe Nicotinamide Riboside (NR) Sales Value by Country (%), 2024 VS 2031

Figure 29. Asia Pacific Nicotinamide Riboside (NR) Sales Value, (2020-2031) & (US$ Million)

Figure 30. Asia Pacific Nicotinamide Riboside (NR) Sales Value by Region (%), 2024 VS 2031

Figure 31. South America Nicotinamide Riboside (NR) Sales Value, (2020-2031) & (US$ Million)

Figure 32. South America Nicotinamide Riboside (NR) Sales Value by Country (%), 2024 VS 2031

Figure 33. Middle East & Africa Nicotinamide Riboside (NR) Sales Value, (2020-2031) & (US$ Million)

Figure 34. Middle East & Africa Nicotinamide Riboside (NR) Sales Value by Country (%), 2024 VS 2031

Figure 35. Key Countries/Regions Nicotinamide Riboside (NR) Sales Value (%), (2020-2031)

Figure 36. Key Countries/Regions Nicotinamide Riboside (NR) Sales Volume (%), (2020-2031)

Figure 37. United States Nicotinamide Riboside (NR) Sales Value, (2020-2031) & (US$ Million)

Figure 38. United States Nicotinamide Riboside (NR) Sales Value by Type (%), 2024 VS 2031

Figure 39. United States Nicotinamide Riboside (NR) Sales Value by Application (%), 2024 VS 2031

Figure 40. Europe Nicotinamide Riboside (NR) Sales Value, (2020-2031) & (US$ Million)

Figure 41. Europe Nicotinamide Riboside (NR) Sales Value by Type (%), 2024 VS 2031

Figure 42. Europe Nicotinamide Riboside (NR) Sales Value by Application (%), 2024 VS 2031

Figure 43. China Nicotinamide Riboside (NR) Sales Value, (2020-2031) & (US$ Million)

Figure 44. China Nicotinamide Riboside (NR) Sales Value by Type (%), 2024 VS 2031

Figure 45. China Nicotinamide Riboside (NR) Sales Value by Application (%), 2024 VS 2031

Figure 46. Japan Nicotinamide Riboside (NR) Sales Value, (2020-2031) & (US$ Million)

Figure 47. Japan Nicotinamide Riboside (NR) Sales Value by Type (%), 2024 VS 2031

Figure 48. Japan Nicotinamide Riboside (NR) Sales Value by Application (%), 2024 VS 2031

Figure 49. South Korea Nicotinamide Riboside (NR) Sales Value, (2020-2031) & (US$ Million)

Figure 50. South Korea Nicotinamide Riboside (NR) Sales Value by Type (%), 2024 VS 2031

Figure 51. South Korea Nicotinamide Riboside (NR) Sales Value by Application (%), 2024 VS 2031

Figure 52. Southeast Asia Nicotinamide Riboside (NR) Sales Value, (2020-2031) & (US$ Million)

Figure 53. Southeast Asia Nicotinamide Riboside (NR) Sales Value by Type (%), 2024 VS 2031

Figure 54. Southeast Asia Nicotinamide Riboside (NR) Sales Value by Application (%), 2024 VS 2031

Figure 55. India Nicotinamide Riboside (NR) Sales Value, (2020-2031) & (US$ Million)

Figure 56. India Nicotinamide Riboside (NR) Sales Value by Type (%), 2024 VS 2031

Figure 57. India Nicotinamide Riboside (NR) Sales Value by Application (%), 2024 VS 2031

Figure 58. Nicotinamide Riboside (NR) Industrial Chain

Figure 59. Nicotinamide Riboside (NR) Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Nicotinamide Riboside (NR) market size from 2025 to 2031? zhanKai

The annual compound growth rate of the global Nicotinamide Riboside (NR) market is 8.3% 2025 to 2031.

What was the global market size of Nicotinamide Riboside (NR) in 2025? shouQi

What was the global market size of Nicotinamide Riboside (NR) in 2031? shouQi

Which companies rank high in the global Nicotinamide Riboside (NR) market? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Global Nicotinamide Riboside (NR) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Nicotinamide Riboside (NR) market size was US$ 27.73 million in 2025 and is forecast to reach a readjusted size of US$ 48.14 million by 2032 with a CAGR of 8.3% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 94
USD 4250.00
(Single User License)
Global Nicotinamide Riboside (NR) Market Research Report 2026
The global Nicotinamide Riboside (NR) market was valued at US$ 27.73 million in 2025 and is anticipated to reach US$ 48.14 million by 2032, at a CAGR of 8.3% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 138
USD 2900.00
(Single User License)
Nicotinamide Riboside (NR)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nicotinamide Riboside (NR) was estimated to be worth US$ 27.73 million in 2025 and is projected to reach US$ 48.14 million, growing at a CAGR of 8.3% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 114
USD 3950.00
(Single User License)
Global Nicotinamide Riboside (NR) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nicotinamide Riboside (NR) market size was US$ 25.8 million in 2024 and is forecast to a readjusted size of US$ 44.8 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 100
USD 4250.00
(Single User License)
Global Nicotinamide Riboside (NR) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nicotinamide Riboside (NR) market is projected to grow from US$ 25.8 million in 2024 to US$ 44.8 million by 2031, at a CAGR of 8.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 162
USD 4900.00
(Single User License)
Global Nicotinamide Riboside (NR) Market Research Report 2025
The global market for Nicotinamide Riboside (NR) was valued at US$ 25.8 million in the year 2024 and is projected to reach a revised size of US$ 44.8 million by 2031, growing at a CAGR of 8.3% during the forecast period.
Published Date: 2025-01-19
Pages: 103
USD 2900.00
(Single User License)
Global Nicotinamide Riboside (NR) Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
Published Date: 2024-04-17
Pages: 174
USD 5600.00
(Single User License)
Global Nicotinamide Riboside (NR) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
Published Date: 2024-04-16
Pages: 143
USD 5900.00
(Single User License)
Global Nicotinamide Riboside (NR) Market Insights, Forecast to 2030
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
Published Date: 2024-04-07
Pages: 106
USD 4900.00
(Single User License)
Nicotinamide Riboside (NR) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
Published Date: 2024-01-18
Pages: 121
USD 3950.00
(Single User License)

Global Nicotinamide Riboside (NR) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Nicotinamide Riboside (NR) market size was US$ 27.73 million in 2025 and is forecast to reach a readjusted size of US$ 48.14 million by 2032 with a CAGR of 8.3% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 94
USD 4250.00 (Single User License)
Global Nicotinamide Riboside (NR) Market Research Report 2026
The global Nicotinamide Riboside (NR) market was valued at US$ 27.73 million in 2025 and is anticipated to reach US$ 48.14 million by 2032, at a CAGR of 8.3% from 2026 to 2032.
Published: 2026-01-05
Pages: 138
USD 2900.00 (Single User License)
Nicotinamide Riboside (NR)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nicotinamide Riboside (NR) was estimated to be worth US$ 27.73 million in 2025 and is projected to reach US$ 48.14 million, growing at a CAGR of 8.3% from 2026 to 2032.
Published: 2026-01-05
Pages: 114
USD 3950.00 (Single User License)
Global Nicotinamide Riboside (NR) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nicotinamide Riboside (NR) market size was US$ 25.8 million in 2024 and is forecast to a readjusted size of US$ 44.8 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 100
USD 4250.00 (Single User License)
Global Nicotinamide Riboside (NR) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nicotinamide Riboside (NR) market is projected to grow from US$ 25.8 million in 2024 to US$ 44.8 million by 2031, at a CAGR of 8.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 162
USD 4900.00 (Single User License)
Global Nicotinamide Riboside (NR) Market Research Report 2025
The global market for Nicotinamide Riboside (NR) was valued at US$ 25.8 million in the year 2024 and is projected to reach a revised size of US$ 44.8 million by 2031, growing at a CAGR of 8.3% during the forecast period.
Published: 2025-01-19
Pages: 103
USD 2900.00 (Single User License)
Global Nicotinamide Riboside (NR) Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
Published: 2024-04-17
Pages: 174
USD 5600.00 (Single User License)
Global Nicotinamide Riboside (NR) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
Published: 2024-04-16
Pages: 143
USD 5900.00 (Single User License)
Global Nicotinamide Riboside (NR) Market Insights, Forecast to 2030
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
Published: 2024-04-07
Pages: 106
USD 4900.00 (Single User License)
Nicotinamide Riboside (NR) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
Published: 2024-01-18
Pages: 121
USD 3950.00 (Single User License)